Lung Cancer
FEATURES
avatar
4766 clinical trials
avatar
2032 cell line models
avatar
31 approved drugs
IMAGE
Lung Cancer
Molecular Synopsis
OVERVIEW
Drugs and clinical candidates

31 drugs have received FDA approval for Lung Cancer:

  • Afatinib Dimaleate
  • Atezolizumab
  • Bevacizumab
  • Brigatinib
  • CH5424802
More

524 drugs have a clinical trial registered for Lung Cancer.

13817 compounds have been tested in Lung Cancer (8334 <= 500nM potency).

Sources: cancer.gov, clinicaltrials.gov, ChEMBL.

Clinical trials
There are 4766 clinical trials for Lung Cancer, 2993 of which have one or more drug interventions, 1773 with no drug intervention.
Cell line models

There are 2032 Cell Line Models for Lung Cancer.

Source: COSMIC
Cell line models

Please note the mappings below are based on an imperfect algorithm. If you notice any anomalies please report them to us.

The following terms have been mapped from clinicaltrials.gov mesh condition terms to Lung Cancer:
  • Adenocarcinoma of Lung
  • Lung Neoplasms
  • Carcinoma, Non-Small-Cell Lung
  • Small Cell Lung Carcinoma
The following terms have been mapped from cancer.gov to Lung Cancer:
  • Small cell lung cancer in patients whose disease has not gotten better with other chemotherapy
  • Non-small cell lung cancer that is anaplastic lymphoma kinase (ALK) positive and has metastasized (spread to other parts of the body)
  • Non-small cell lung cancer that has metastasized. It is used in patients whose disease got worse during or after treatment with platinum chemotherapy. Patients whose cancer has certain gene mutations should receive nivolumab only if their disease got worse after treatment with FDA-approved therapy for the gene mutations
  • Non-small cell lung cancer that is anaplastic lymphoma kinase (ALK) positive and has metastasized (spread to other parts of the body). It is used in patients whose disease got worse after treatment with:Crizotinib and at least one other ALK inhibitor therapy for metastatic disease, or
  • Non-small cell lung cancer (NSCLC) that has metastasized (spread to other parts of the body). It is used as first-line treatment in patients whose tumors have certain EGFR gene mutations
More